Cold Plasma market  in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 15.0% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Factors such as the increasing prevalence of food-borne diseases, increasing use of cold plasma in wound healing and cancer treatment, innovation in textile production, and benefits of cold plasma for different industries are expected to drive the growth of the cold plasma industry.

Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187065928

Based on industry, the polymer & plastic, textile, electronics & semiconductors, food & agriculture, and medical industries are the leading adopters of cold plasma technology. Of these, the polymer & plastic industry segment accounted for the largest share of the market in 2020. Surface Treatment of the cold plasma technology for the polymer & plastic industry is expected to result in driving the growth of the segment during the forecast period.

Atmospheric cold plasma and low-pressure cold plasma are the two types of regimes available in the commercial market. The atmospheric cold plasma segment is expected to exhibit the fastest CAGR of the cold plasma market during the forecast period. Its advantages over low-pressure cold plasma, low cost, and environment-friendliness have driven the growth of this market segment.

Geographically, the cold plasma market in Europe accounted for the largest share in 2020 due to the presence of a large number of cold plasma companies and growing R&D activity. The Asia Pacific market is expected to register the highest growth during the forecast period, mainly due to the growing demand for cold plasma technology in China, India, Japan, and South Korea, among other APAC countries. Considering this factor, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.

Key Market Players:

The prominent players in the cold plasma market include Apyx Medical Corporation (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i (UK), Relyon Plasma GmbH, (Germany), Henniker Plasma (UK), Enercon Industries (US), AcXys Plasma Technologies (France), Plasmatreat (Germany), Tantec A/S (Denmark), Europlasma (Belgium), Thierry Corporation (Germany), Surfx Technologies (US), SOFTAL Corona & Plasma (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), terraplasma GmbH (Germany), Molecular Plasma Group (Germany), and CINOGY GmbH (Germany), US Medical Innovation (US).

Request for FREE Sample Pages:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=187065928

Hypothetic Challenges of Cold Plasma Market in Near Future:

  • Competition from alternative medical treatments: Cold plasma therapy is a relatively new medical treatment, and as such it faces competition from more established treatments. As more research is conducted and more treatments are developed, the efficacy of cold plasma therapy may be challenged.
  • High cost of equipment: Cold plasma equipment is expensive, and this may be a barrier to entry for prospective buyers. The cost of equipment and installation could be a major challenge for cold plasma market in the near future.
  • Lack of awareness: While the medical community is aware of cold plasma therapy and its potential benefits, the general public may not be as familiar with it. This could be a challenge for the cold plasma market, as it may have difficulty in reaching potential customers.
  • Regulatory hurdles: As with any new technology, cold plasma therapy may face regulatory hurdles. This could present a challenge for the cold plasma market, as it may have difficulty in getting approval to market its products.